Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             124 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 0-28. Adjuvant high dose chemotherapy (HD CT) without bone marrow rescue in breast cancer patients (b.c. pts) with 10 or more positive nodes (N ≥ 10): preliminary results of an Italian breast cancer adjuvant study group (GROCTA) trial Amoroso, D.
 1997
 6 4 p. 232-
1 p.
 artikel
2 0-32. A dose intensity study of epirubicin weekly for disseminated breast cancer Malmström, P.
 1997
 6 4 p. 233-234
2 p.
 artikel
3 0-65. Allelic imbalance at chromosome 17p13.3(YNZ22) and poor prognosis in breast cancer Thompson, A.M.
 1997
 6 4 p. 243-
1 p.
 artikel
4 0-104. Alterations to oestrogen receptor in mammographically detected invasive breast carcinomas Chappell, S.
 1997
 6 4 p. 254-
1 p.
 artikel
5 0-36. An assessment of tissue polypeptide specific antigen (TPS) in the management of breast carcinoma Mulhall, K.
 1997
 6 4 p. 234-235
2 p.
 artikel
6 0-18. Antioestrogen therapy does not affect apoptosis or mitosis in comedo ductal carcinoma in situ (DCIS) Gandhi, A.
 1997
 6 4 p. 229-230
2 p.
 artikel
7 0-41. An update on breast screening for women aged < 50: results from a family history clinic Kollias, J.
 1997
 6 4 p. 236-
1 p.
 artikel
8 0-66. Applying the Nottingham prognostic index to a Swedish population Sundquist, M.
 1997
 6 4 p. 243-
1 p.
 artikel
9 0-101. A randomised controlled trial investigating the psychological impact of same-day diagnosis at a ‘one stop’ breast clinic versus conventional clinic arrangements Harcourt, D.M.
 1997
 6 4 p. 253-
1 p.
 artikel
10 0-89. A randomised controlled trial of early versus standard discharge after breast cancer surgery Bundred, N.J.
 1997
 6 4 p. 249-
1 p.
 artikel
11 0-74. A randomised, double blind, parallel-group trial to evaluate the effect of ‘Arimidex’ (anastrozole) on the pharmacokinetics of tamoxifen in postmenopausal breast cancer patients Dowsett, M.
 1997
 6 4 p. 245-
1 p.
 artikel
12 0-48. A randomised pilot study of HRT in breast cancer patients: the combined effects of tamoxifen and HRT on the endometrium Marsden, J.
 1997
 6 4 p. 238-
1 p.
 artikel
13 0-80. A randomised prospective study of preservation of the intercostobrachial nerve in axillary node clearance Abdullah, T.I.
 1997
 6 4 p. 247-
1 p.
 artikel
14 0-29. A randomized phase II study of high-dose chemotherapy in high-risk breast cancer Rulgers, E.
 1997
 6 4 p. 232-233
2 p.
 artikel
15 0-44. Are we using the right questionnaires when screening for anxiety and depression in women with early breast cancer? Hall, A.
 1997
 6 4 p. 237-
1 p.
 artikel
16 0-87. Assessing the adequacy of mastectomy by flap biopsies Doughty, J.C.
 1997
 6 4 p. 249-
1 p.
 artikel
17 0-90. Association of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) with microvessels density in invasive ductal carcinoma of the breast Venizelos, B.
 1997
 6 4 p. 249-250
2 p.
 artikel
18 0-82. Audit of selective management of the axilla in elderly patients with operable breast cancer Al-Hilaly, M.A.
 1997
 6 4 p. 247-
1 p.
 artikel
19 0-93. Autocrine and paracrine stimulation of breast cancer by fibroblast growth factors Marsh, S.
 1997
 6 4 p. 250-251
2 p.
 artikel
20 0-67. Automated grading in a prognostic index Kohlhardt, S.R.
 1997
 6 4 p. 243-
1 p.
 artikel
21 0-78. Axillary dissection of level I and II - also when tumours are small? The DBCG recommendation Axelsson, C.K.
 1997
 6 4 p. 246-
1 p.
 artikel
22 0-77. Axillary node recurrence following node sample and selective regional radiotherapy Kumar, A.
 1997
 6 4 p. 246-
1 p.
 artikel
23 0-6. Axillary surgery in patients with breast cancer being treated by breast conservation: a randomised trial of node sampling and axillary clearance Chetty, U.
 1997
 6 4 p. 226-
1 p.
 artikel
24 0-15. bcl-2 and p53 protein expression in ductal carcinoma in situ Quinn, C.M.
 1997
 6 4 p. 228-229
2 p.
 artikel
25 Bibliography of the breast 1997
 6 4 p. B13-B15
nvt p.
 artikel
26 0-56. Breast conserving surgery for invasive breast cancer: risk factors for ipsilateral breast tumour recurrences Dalberg, K.
 1997
 6 4 p. 240-
1 p.
 artikel
27 0-19. Breast conserving surgery is appropriate for localised ductal carcinoma in situ Gandhi, A.
 1997
 6 4 p. 230-
1 p.
 artikel
28 0-22. Can mastectomy prevent breast cancer? Iddon, J.
 1997
 6 4 p. 230-231
2 p.
 artikel
29 0-33. Can sentinel lymph node biopsy avoid axillary dissection in node negative breast cancer patients? Zurrida, S.
 1997
 6 4 p. 234-
1 p.
 artikel
30 0-95. C-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer Knowlden, J.M.
 1997
 6 4 p. 251-
1 p.
 artikel
31 0-10. Change in expression of ER and bcl-2 predict for quality and duration of response in endocrine sensitive breast cancer Kenny, F.S.
 1997
 6 4 p. 227-
1 p.
 artikel
32 0-97. Clinical audit of a protocol for the management of clinically benign breast lumps Kohlhardt, S.R.
 1997
 6 4 p. 252-
1 p.
 artikel
33 0.31. CMF vs tamoxifen (TAM) plus goserelin (GOS) as adjuvant treatment of ER positive (+VE) preperimenopausal breast cancer patients (pts). Preliminary results of an ongoing Italian breast cancer adjuvant study group (GROCTA) trial Boccardo, F.
 1997
 6 4 p. 233-
1 p.
 artikel
34 Combination of interferon and tamoxifen for patients with advanced breast cancer and negative oestrogen receptors Peretz, T.
 1997
 6 4 p. 190-193
4 p.
 artikel
35 0-71. Combination rivizor® (vorozole) and ZoladexTM (goserelin) in premenopausal breast cancer: towards maximal oestrogen deprivation Dowsett, M.
 1997
 6 4 p. 244-
1 p.
 artikel
36 Combined image-guided excision of mammographically detected non-palpable breast lesions: a new technique Isgar, B.
 1997
 6 4 p. 223-
1 p.
 artikel
37 0-39. Continuous 5-FU for locally advanced breast cancer - the Edinburgh Breast Unit experience Cameron, D.A.
 1997
 6 4 p. 235-236
2 p.
 artikel
38 0-96. Cyclin D1 overexpression predicts for poor prognosis in ER positive breast cancer Kenny, F.S.
 1997
 6 4 p. 251-252
2 p.
 artikel
39 Diary of events 1997
 6 4 p. 224-
1 p.
 artikel
40 0-83. Differential expression of growth factors in metastases to different sites Downey, S.E.
 1997
 6 4 p. 247-248
2 p.
 artikel
41 0-60. Differentiation of benign radial scar (complex sclerosing lesion) from carcinoma by 14G core biopsy (CB): is surgical excision of radial scars necessary? Michell, M.J.
 1997
 6 4 p. 241-
1 p.
 artikel
42 0-58. Does incident round screening work? A comparison of prognostic factors of prevalent and incident carcinoma Evans, A.J.
 1997
 6 4 p. 241-
1 p.
 artikel
43 0-99. Doppler ultrasound measurements in breast disease Robinson, T.M.
 1997
 6 4 p. 252-
1 p.
 artikel
44 Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer Robertson, J.F.R.
 1997
 6 4 p. 186-189
4 p.
 artikel
45 0-106. Duration of tamoxifen therapy in women with early, operable breast cancer over the age of fifty Potyka, I.
 1997
 6 4 p. 254-
1 p.
 artikel
46 0-43. Early diagnosis of inherited breast cancer Møller, P.
 1997
 6 4 p. 236-237
2 p.
 artikel
47 0-105. Electropotential measurements as a new modality for breast cancer diagnosis: results from a prospective multicentre trial Cuzick, J.
 1997
 6 4 p. 254-
1 p.
 artikel
48 0-47. Epithelial proliferation and hormone receptor status in the normal postmenopausal breast and the effects of HRT use Hargreaves, D.F.
 1997
 6 4 p. 238-
1 p.
 artikel
49 0-55. Factors influencing local recurrence following breast conservation therapy Shrestha, S.
 1997
 6 4 p. 240-
1 p.
 artikel
50 0-68. Fraction of normal remaining life: a new method of defining cure in early breast cancer Vaidya, J.S.
 1997
 6 4 p. 243-
1 p.
 artikel
51 0-8. Germ-line mutations in BRCA1 and BRCA2 are seldom found in `unilateral breast cancer only' families Hogervorst, F.
 1997
 6 4 p. 227-
1 p.
 artikel
52 0-35. Guiding systemic therapy in metastatic breast cancer by blood tumour markers Robertson, J.F.R.
 1997
 6 4 p. 234-
1 p.
 artikel
53 0-23. High levels of loss of heterozygosity at the ATM and FHIT genes in low grade breast cancers Man, S.
 1997
 6 4 p. 231-
1 p.
 artikel
54 0-38. Identification of clinical factors predicting outcome following primary chemotherapy for operable breast cancer Ellis, P.A.
 1997
 6 4 p. 235-
1 p.
 artikel
55 Impact of magnetic resonance imaging in determining surgical management in breast cancer Davidson, T.
 1997
 6 4 p. 177-182
6 p.
 artikel
56 Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody Connor, A.J.M.
 1997
 6 4 p. 171-176
6 p.
 artikel
57 0-50. Investigation of the exon 5-deleted oestrogen receptor variant in primary human breast cancer Bryant, S.
 1997
 6 4 p. 239-
1 p.
 artikel
58 0-84. Is measurement of CEA of benefit during follow up in patients with primary breast carcinoma McLaughlin, R.
 1997
 6 4 p. 248-
1 p.
 artikel
59 0-75. Letrozole as primary medical therapy for locally advanced breast cancer Dixon, J.M.
 1997
 6 4 p. 245-246
2 p.
 artikel
60 0-20. Local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (DCIS) of the breast Sibbering, D.M.
 1997
 6 4 p. 230-
1 p.
 artikel
61 0-54. Local irradiation reduces breast relapses in the presence of systemic adjuvant therapy Potyka, I.
 1997
 6 4 p. 240-
1 p.
 artikel
62 0-86. Local recurrence of breast cancer: new concepts about its biology and clinical relevance Vaidya, J.S.
 1997
 6 4 p. 248-249
2 p.
 artikel
63 0-53. Long term follow up of breast cancer patients treated by conservation Jack, W.J.L.
 1997
 6 4 p. 239-240
2 p.
 artikel
64 0-69. Long-term follow-up of elderly patients randomised to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer Kenny, F.S.
 1997
 6 4 p. 244-
1 p.
 artikel
65 0-24. Loss of heterozygosity in premenopausal bilateral breast cancer Kollias, J.
 1997
 6 4 p. 231-
1 p.
 artikel
66 0-1. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer Gill, P.G.
 1997
 6 4 p. 225-
1 p.
 artikel
67 Measures of proliferation in breast cancer: practicality and utility Page, D.L.
 1997
 6 4 p. 169-170
2 p.
 artikel
68 0-76. Morbidity of axillary surgery for breast cancer Dixon, J.M.
 1997
 6 4 p. 246-
1 p.
 artikel
69 N3 category in the TNM classification of breast cancer needs to be defined more precisely Semiglazov, V.F.
 1997
 6 4 p. 217-220
4 p.
 artikel
70 0-2. New approach to therapeutic and diagnostic management of screen detected mammographic abnormalities: the ABBI system Menon, M.
 1997
 6 4 p. 225-
1 p.
 artikel
71 0-45. Oestrogen receptor content assessed immunohistochemically with ER1D5 predicts recurrence free survival better than the DCC method Grabau, D.Aa.
 1997
 6 4 p. 237-
1 p.
 artikel
72 0-103. One year psychosocial outcomes for women attending a breast cancer Family History Clinic Hopwood, P.
 1997
 6 4 p. 253-254
2 p.
 artikel
73 0-52. Outcome relative to tumour bed status for 300 patients treated by breast-conserving surgery Macmillan, R.D.
 1997
 6 4 p. 239-
1 p.
 artikel
74 Overexpression of PDGF receptor β in dermal fibroblasts of lymphangitic post radiotherapy relapses of breast carcinoma Pierga, J-Y.
 1997
 6 4 p. 206-211
6 p.
 artikel
75 0-63. Pathological and immunohistochemical prognostic factors in clinical stage I breast cancer patients Walker, R.A.
 1997
 6 4 p. 242-
1 p.
 artikel
76 0-17. Pathological reporting of ductal carcinoma in situ (DCIS) in the UK trial Houghton, J.
 1997
 6 4 p. 229-
1 p.
 artikel
77 0-73. Pharmacokinetic interaction between letrozole and tamoxifen in postmenopausal patients with advanced breast cancer Dowsett, M.
 1997
 6 4 p. 245-
1 p.
 artikel
78 0-51. Positive cavity biopsy does not predict early local recurrence following breast conserving surgery for invasive carcinoma Christie, R.
 1997
 6 4 p. 239-
1 p.
 artikel
79 p53 overexpression is a prognostic indicator in poorly differentiated, node negative and T1/T2 invasive ductal breast cancer patients André, S.
 1997
 6 4 p. 194-201
8 p.
 artikel
80 0-100. Preliminary in vitro studies of electrical impedance mammography (EIM): a future technique for non-invasive breast tissue imaging? Tunstall, B.
 1997
 6 4 p. 253-
1 p.
 artikel
81 0-109. Preliminary report: the CRC adjuvant breast trial for patients under the age of fifty Wells, U.M.
 1997
 6 4 p. 255-
1 p.
 artikel
82 0-40. Preoperative diagnosis of 249 screen detected breast cancers using a combination of core biopsy and FNAC Evans, A.J.
 1997
 6 4 p. 236-
1 p.
 artikel
83 0-13. Preoperative tamoxifen: the effect upon cytological prognostic markers Daltrey, I.R.
 1997
 6 4 p. 228-
1 p.
 artikel
84 0-3. Prognostic impact of tumour cell detection in patients with early (T1) and locally advanced breast cancer Diel, I.J.
 1997
 6 4 p. 225-
1 p.
 artikel
85 0-27. Prospective study of relationship of PTHrP production to bone metastasis and breast cancer survival Bundred, N.J.
 1997
 6 4 p. 232-
1 p.
 artikel
86 0-64. pS2 expression provides additional useful prognostic information after 7 years follow-up Thompson, A.M.
 1997
 6 4 p. 242-243
2 p.
 artikel
87 0-26. Psychosocial implications of prophylactic bilateral mastectomy Thirlaway, K.
 1997
 6 4 p. 231-232
2 p.
 artikel
88 0-12. Qualitative effects of letrozole as primary medical therapy on in situ oestrogen synthesis and endogenous oestrogen levels within the breast Miller, W.R.
 1997
 6 4 p. 228-
1 p.
 artikel
89 Radiographers as readers in breast screening: experience with a ‘red dot’ method Mucci, B.
 1997
 6 4 p. 183-185
3 p.
 artikel
90 0-88. Reducing cardiac doses in post-operative irradiation of breast cancer patients Canney, P.A.
 1997
 6 4 p. 249-
1 p.
 artikel
91 0-81. Regional recurrence following a positive axillary node sampling in patients with breast cancer. Is further treatment necessary? Christie, R.
 1997
 6 4 p. 247-
1 p.
 artikel
92 0-49. Relationship between tamoxifen duration and endometrial thickness Love, C.D.B.
 1997
 6 4 p. 238-
1 p.
 artikel
93 0-37. Retention of functional oestrogen receptor at relapse on tamoxifen: implications for second-line endocrine therapy Johnston, S.R.D.
 1997
 6 4 p. 235-
1 p.
 artikel
94 0-7. Risk of breast cancer in cystic disease of the breast Dixon, J.M.
 1997
 6 4 p. 226-227
2 p.
 artikel
95 0-72. Rivizor® versus aminoglutethimide (AG) in the second-line endocrine treatment of postmenopausal patients with advanced breast cancer (ABC) following tamoxifen failure Houston, S.J.
 1997
 6 4 p. 244-245
2 p.
 artikel
96 Role of neoadjuvant chemotherapy in the treatment of stage 1 breast cancer della Rovere, G.Querci
 1997
 6 4 p. 221-223
3 p.
 artikel
97 0-85. Role of radiotherapy in early breast cancer and the salvaging of patients with local relapse Spooner, D.
 1997
 6 4 p. 248-
1 p.
 artikel
98 0-16. Screen detected DCIS: surgeons think they know best! Baker, C.B.
 1997
 6 4 p. 229-
1 p.
 artikel
99 0-42. Screening by mammography women with a family history of breast cancer Lalloo, F.
 1997
 6 4 p. 236-
1 p.
 artikel
100 0-21. Screening for mutations in ataxia-telangiectasia gene in breast cancer patients Ramsay, J.
 1997
 6 4 p. 230-
1 p.
 artikel
101 0-91. Serum vascular endothelial cell marker (VCAM) and e-selectin (Esel) are endothelial markers for angiogenesis in early and advanced breast cancer Byrne, G.J.
 1997
 6 4 p. 250-
1 p.
 artikel
102 0-30. Sexuality in women receiving chemotherapy for breast cancer Clemons, M.J.
 1997
 6 4 p. 233-
1 p.
 artikel
103 0-5. Static disease (no change) is an important remission criteria in patients treated with the aromatase inhibitor anastrozole Robertson, J.F.R.
 1997
 6 4 p. 226-
1 p.
 artikel
104 0-9. Tamoxifen alters the relationship between bcl-2 and apoptosis in breast cancer Cameron, D.A.
 1997
 6 4 p. 227-
1 p.
 artikel
105 0-4. Tamoxifen: assessment of the balance of benefits and risks of long-term treatment Davies, C.
 1997
 6 4 p. 226-
1 p.
 artikel
106 Tamoxifen therapy for cyclical mastalgia: dose randomized trial Semiglazov, V.F.
 1997
 6 4 p. 212-213
2 p.
 artikel
107 0-92. Telomerase-telomere expression during the progression of human breast cancer Imam, S.A.
 1997
 6 4 p. 250-
1 p.
 artikel
108 0-70. The addition of surgery to tamoxifen as primary treatment of early breast cancer in women over 70, a multicentre trial Latteier, J.
 1997
 6 4 p. 244-
1 p.
 artikel
109 0-46. The availability of oestrogen receptor (ER) status strongly influences recommendations for adjuvant systemic therapy in higher risk breast cancer patients Wishart, G.C.
 1997
 6 4 p. 237-238
2 p.
 artikel
110 The difficult screening mammogram: value of early follow-up Brown, S.R.
 1997
 6 4 p. 214-216
3 p.
 artikel
111 0-14. The effect of antioestrogens on the “high risk” breast Bramley, M.D.
 1997
 6 4 p. 228-
1 p.
 artikel
112 0-57. The effect of hormone replacement therapy on the sensitivity of mammographic screening Stallard, S.
 1997
 6 4 p. 240-241
2 p.
 artikel
113 0-98. The effect of needle size and local anaesthetic on the pain and diagnostic accuracy of breast FNAC Daltrey, I.R.
 1997
 6 4 p. 252-
1 p.
 artikel
114 0-79. The impact of inadequate axillary surgery on survival and the influence of age Kingsmore, D.B.
 1997
 6 4 p. 246-247
2 p.
 artikel
115 0-25. The incidence of BRCA1 and BRCA2 mutations in women with bilateral or early onset (under 35 years) breast cancer Marafie, M.
 1997
 6 4 p. 231-
1 p.
 artikel
116 0-59. The National health service breast screening programme in the trent region — are we meeting the targets? Holland, P.A.
 1997
 6 4 p. 241-
1 p.
 artikel
117 0-94. The partial inhibition of AP-1-induced gene transcription by antioestrogen treatment in transfected MCF7 cells McClelland, R.
 1997
 6 4 p. 251-
1 p.
 artikel
118 0-102. The psychological impact of a rapid diagnosis service for women with symptoms suggestive of breast cancer Hopwood, P.
 1997
 6 4 p. 253-
1 p.
 artikel
119 0-107/0-108. The UKCCCR breast screening frequency trial: results on predicted mortality Day, N.E.
 1997
 6 4 p. 254-255
2 p.
 artikel
120 0-62. The value of contralateral breast screening in primary breast cancer follow-up Kollias, J.
 1997
 6 4 p. 242-
1 p.
 artikel
121 0-11. Three week preoperative tamoxifen treatment: the effect on oestrogen receptor levels in primary breast tumours: a flow cytometric study Browell, D.A.
 1997
 6 4 p. 227-228
2 p.
 artikel
122 Twelve years of experience of breast cancer at the Institut Curie: improvement of survival and value of screening mammographics Salmon, R.J.
 1997
 6 4 p. 202-205
4 p.
 artikel
123 0-61. Use of Tc-99 labelled colloidal albumin for preoperative and intraoperative localization of non-palpable breast lesions Galimberti, V.
 1997
 6 4 p. 242-
1 p.
 artikel
124 0-34. Vascular targeting of retroviral gene therapy in breast cancer Chan, H.Y.
 1997
 6 4 p. 234-
1 p.
 artikel
                             124 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland